enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Sacubitril/valsartan - Wikipedia

   en.wikipedia.org/wiki/Sacubitril/valsartan

   Sacubitril/valsartan, sold under the brand name Entresto among others, is a fixed-dose combination medication for use in heart failure. It consists of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan .

3. Sacubitril - Wikipedia

   en.wikipedia.org/wiki/Sacubitril

   Sacubitril (/ s ə ˈ k juː b ɪ t r ɪ l /; INN) is an antihypertensive drug used in combination with valsartan.The combination drug sacubitril/valsartan, known during trials as LCZ696 and marketed under the brand name Entresto, is a treatment for heart failure. [1]

4. How much does Entresto cost with Medicare? - AOL

   www.aol.com/much-does-entresto-cost-medicare...

   Entresto helps manage chronic heart failure by reducing the effort necessary for the heart to pump blood around the body. This article explains how much a person with Medicare Part D typically ...

5. Valsartan - Wikipedia

   en.wikipedia.org/wiki/Valsartan

   Valsartan, sold under the brand name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. [8] It belongs to a class of medications referred to as angiotensin II receptor blockers (ARBs).

6. Novartis loses initial bid to block generic of best-selling ...

   www.aol.com/news/novartis-loses-initial-bid...

   The judge also rejected Novartis' argument that a ruling against the company would cause "irreparable harm" by triggering a wave of generic Entresto launches by other drugmakers.

7. Antihypertensive - Wikipedia

   en.wikipedia.org/wiki/Antihypertensive

   Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke, heart failure, kidney failure and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34% and of ischaemic heart disease by 21%, and can reduce the likelihood of dementia ...

8. Novartis lifts profit forecast for second time on Cosentyx ...

   www.aol.com/news/novartis-raises-2024-profit...

   Swiss drugmaker Novartis raised its 2024 earnings guidance for the second time on Thursday, driven by a gain in prescriptions for drugs including heart failure treatment Entresto and arthritis ...

9. Nephrotoxicity - Wikipedia

   en.wikipedia.org/wiki/Nephrotoxicity

   Nephrotoxicity is toxicity in the kidneys. It is a poisonous effect of some substances, both toxic chemicals and medications, on kidney function. [1] There are various forms, [2] and some drugs may affect kidney function in more than one way. Nephrotoxins are substances displaying nephrotoxicity.